Specialized technical advisory providing fractional leadership and R&D oversight for life science organizations. Bridging the gap between PhD-level innovation and commercial asset strategy.
Collaborated with early-stage leadership to identify high-value technical whitespace. Architected and authored new IP filings for hydrogel-based delivery systems to expand product pipelines and competitive moats.
Led the development of investor narratives and commercial roadmaps. Managed global CRO networks for IND-enabling studies and directed Search & Evaluation efforts to license emerging platform technologies.
Partnering with established firms to pilot "off-roadmap" initiatives, providing a Scientist-Operator lens to test new strategic directions without disrupting core laboratory operations.